Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
• S2 Statistical Solutions (Cincinnati, OH), a provider of data mining and economic analysis for medical device, diagnostic, and biopharmaceutical companies, has appointed Tina Hunter, PhD, as Senior Director of Analytics.
• Jonathan M. Fishbein has been appointed Vice President and Global Head for the Infectious Diseases Therapeutic Area Group at ICON (Dublin, Ireland) where he will oversee the growth and management of the infectious disease portfolio.
Tina Hunter, PhD
• Laurie Heilmann has been appointed ACR Image Metrix's (Philadelphia, PA) new Director of Business Development and Elena Kachanova has been appointed Clinical Project Manager.
• Joining MediciGlobal (King of Prussia, PA) is Judy Berwick as Account Executive.
• With 10 years of experience in the biopharmaceutical industry, Bill Kane has joined Almac (Craigavon, Northern Ireland) as Director of Quality Assurance and Regulatory Compliance. He will be responsible for supporting internal, client, and agency audits, as well as improving internal Quality and Compliance programs.
Jonathan M. Fishbein
• ACM Global (Rochester, NY) has added several new people to its team including Zoe Denham as Project Manager, Barnaby le Clercq as Business Development Director, and Ros McCabe, PhD, as Analytical Scientist. In addition, ACM Global has appointed Hua-Kang Wu, PhD, as Director of Molecular and Cellular Diagnostics, Cholpady P. Kamath, MD, Director of Anatomic Pathology, and promoted Tracy Hendershott to Executive Director, Global Operations.
• The Patient Recruitment Organization Steering Committee (Washington, DC) has elected Robert Loll as Vice Chairman.
• Mary Spellman, MD, will lead Integrium's (Tustin, CA) new Dermatology Clinical Research Group.
Laurie Heilmann
Pharmaceutical Research and Manufacturers of America (Washington, DC) has hired John J. Castellani as President and Chief Executive Officer.
• Virtify (Cambridge, MA) has promoted John P. Murgo to the role of Chief Operating Officer. He will manage the integration of people and processes within sales, marketing, product implementation, and customer support in addition to his existing responsibilities as Executive Vice President/Chief Financial Officer.
Judy Berwick
• With more than a decade of drug development experience, John Q. Kamerud, PhD, will lead Covance's (Princeton, NJ) North American principal investigator teams, providing large molecule bioanalytical services as Associate Director of Immunochemistry Services.
• TRAC (Corwnall, UK), a regulatory affairs specialist, has made several new additions including Debbi Finlay and Mike May as members of the Regulatory Affairs Team and Natalie Grogan as Marketing Manager.
The newest additions to TRAC's staff pictured with company Directors Sarah Trethowan and Jonathan Trethowan. From left to right: Sarah Trethowan, Mike May, Debbie Finlay, Natalie Grogan, and Jonathan Trethowan.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.